[1] |
Ozülker T,Kücüköz Uzun A,Oztllker F,et al.Comparison of 88F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.Nucl Med Commun,2010,31(6):597-603.
|
[2] |
Messiou C,Cook G,deSouza NM.Imaging metastatic bone disease from carcinoma of the prostate.Br J Cancer.2009,101(8):1225-1232.
|
[3] |
Bury T,Barreto A,Daenen F,et ah Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.Eur J Nucl Med,1998,25(9):1244-1247.
|
[4] |
Cheran SK,Herndon JE 2nd,Patz EF Jr.Comparison of wholebody FDG-PET to bone scan for detection of bone melastases in patients with a new diagnosis of lung cancer.Lung Cancer,2004,44(3):317-325.
|
[5] |
Stefan K,Andreas K,Buck Felix M,et al.Detection of bone metastases in patients with lung cancer 99mTc-MDP planar bone scintigraphy,88F-fluoride PET or 88F-FDG PET/CT.Eur J Nucl Med Mol Imaging,2009,36(11):1807-1812.
|
[6] |
Marom EM,McAdams HP,Erasnms J,et al.Staging non-small cell lung cancer with whole-body PET.Radiology,1999,212(3):803-809.
|
[7] |
Buck AK,Herrmann K,Stargardt T,et al.Economic evaluation of PET and PET/CT in Oncology:evidence and methodologic approaches.J Nucl Med Technol,2010,38(1):6-17.
|
[8] |
Cook GJ.Skeletal metastases:what is the future role for nuclear medicine?.Eur J Nucl Med Mol hnaging,2009,36(11):1807-1812.
|
[9] |
Ito S,Kato K,Ikeda M,et al.Comparison of 88F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid eaneer.J Nucl Med,2007,48(6):889-895.
|
[10] |
Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imagingingmetastatic breast cancer.J Clin Oncol,2004,22(14):2942-2953.
|
[11] |
Goya M,Ishii G,Miyamoto S,et al.Prostate-specific antigen induces apoptosis of osteoclast precursors:potential role in osteoblastie bone metastases of prostate cancer.Prostate,2006,66(15):1573-1584.
|
[12] |
Mundy GR.Metastasis to bone:causes,consequences and thera-peutic opportunities.Nat Rev Cancer,2002,2(8):584-593.
|
[13] |
Uematsu T,Yuen S,Yukisawa S.et al.Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.AJR Am J Roentgenol,2005,184(4):1266-1273.
|
[14] |
Ohla M,Tokuda Y,Suzuki Y evaluation of bony metastases et al.Whole body PET for the in patients with breast cancer:comparisnn with 99mTc-MDP bone scintigraphy.Nucl Med Comnmn 2001,22(8):875-879.
|
[15] |
Schin'meister H,Guhlmann A,Eisner K,et al.Sensitivity in detecting osseous lesions depends on anatomic localization:planar bone scintigraphy versus tSF PET.J Nucl Med,1999,40(10):1623-1629.
|
[16] |
Metser U,Lerman H,Blank A,et al.Malignant involvement of the spine:assessment by 88F-FDG PET/CT.J Nucl Med,2004,45(2):279-284.
|
[17] |
Nakai T,Okuyama C,Kubota T,et al.Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.EurJ Nucl Med Mol Imaging,2005,32(11):1253-1258.
|